[1]
Proietti, I. et al. 2023. Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome. Dermatology Practical & Conceptual. 13, 3 (Jul. 2023), e2023178. DOI:https://doi.org/10.5826/dpc.1303a178.